Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Kohanbash

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Immunological Investigations|September 29, 2012
Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-developmentGary Kohanbash, Hideho Okada
Seminars in Cancer Biology|January 3, 2012
MicroRNAs and STAT interplayGary Kohanbash, Hideho Okada
Journal for Immunotherapy of Cancer|March 19, 2025
NK cells link immune-checkpoint blockade immunotherapy and response in melanoma brain metastasesGary Kohanbash, Stephen C Frederico, Itay Raphael
The International Journal of Biochemistry & Cell Biology|February 11, 2010
MicroRNAs in immune regulation--opportunities for cancer immunotherapyHideho Okada, Gary Kohanbash, Michael T Lotze
Frontiers in Immunology|January 26, 2023
Pre-clinical models for evaluating glioma targeted immunotherapiesStephen C Frederico, Xiaoran Zhang, Baoli Hu, et al.
Biochemical and Biophysical Research Communications|February 14, 2015
Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activityAkemi Kosaka, Takayuki Ohkuri, Maki Ikeura, et al.
Ebiomedicine|January 6, 2024
Glioblastoma vaccines: past, present, and opportunitiesZujian Xiong, Itay Raphael, Michael Olin, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 17, 2024
Immunotherapy for pediatric low-grade gliomasIan F Pollack, James Felker, Stephen C Frederico, et al.
Bioconjugate Chemistry|May 28, 2025
Developing and Characterizing the Tumor-Targeting Efficiency of an Anti-EphA2-CD11b Bispecific AntibodyPeggy A Birikorang, Dominic M Menendez, Robert Edinger, et al.
STAR Protocols|March 2, 2023
Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse modelsApeng Chen, Yapeng Chao, Han Zou, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Immunological Investigations|September 29, 2012
Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-developmentGary Kohanbash, Hideho Okada
Seminars in Cancer Biology|January 3, 2012
MicroRNAs and STAT interplayGary Kohanbash, Hideho Okada
Journal for Immunotherapy of Cancer|March 19, 2025
NK cells link immune-checkpoint blockade immunotherapy and response in melanoma brain metastasesGary Kohanbash, Stephen C Frederico, Itay Raphael
The International Journal of Biochemistry & Cell Biology|February 11, 2010
MicroRNAs in immune regulation--opportunities for cancer immunotherapyHideho Okada, Gary Kohanbash, Michael T Lotze
Frontiers in Immunology|January 26, 2023
Pre-clinical models for evaluating glioma targeted immunotherapiesStephen C Frederico, Xiaoran Zhang, Baoli Hu, et al.
Biochemical and Biophysical Research Communications|February 14, 2015
Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activityAkemi Kosaka, Takayuki Ohkuri, Maki Ikeura, et al.
Ebiomedicine|January 6, 2024
Glioblastoma vaccines: past, present, and opportunitiesZujian Xiong, Itay Raphael, Michael Olin, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 17, 2024
Immunotherapy for pediatric low-grade gliomasIan F Pollack, James Felker, Stephen C Frederico, et al.
Bioconjugate Chemistry|May 28, 2025
Developing and Characterizing the Tumor-Targeting Efficiency of an Anti-EphA2-CD11b Bispecific AntibodyPeggy A Birikorang, Dominic M Menendez, Robert Edinger, et al.
STAR Protocols|March 2, 2023
Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse modelsApeng Chen, Yapeng Chao, Han Zou, et al.
Pageof 9